SlideShare a Scribd company logo
1 of 30
Story of two siblings with
“Chubby Cheeks”
Dept. of Pediatric Gastroenterology
SGPGIMS, Lucknow
Chubby cheeks – cute babies?
GSD
workup
negative

Exposure to
fruit juices
Affected SIB

Neonatal
cholestasis
TB:7.4
DB:3.8
AST:321
ALT: 138
T. Prot:3.9
Alb: 2.0
ALP:1672
GGT:66

Resolved
by 5mo

Sep 2008 (3mo)

Acute
encephalopathy

Liver biopsy:
early cirrhosis
macrovesicular
steatosis

Urine
NGRS
+
High
AFP

ABG/ Blood sugar/
U. ketones/ Lactate
All normal !
Ammonia :119
(Normal:11-47)

GAL1PUT &
Epimerase
normal

Persisting:
Doll like facies
Organomegaly
AST/ALT: 253/180
T. Prot/ Alb: 4.0/1.8
ALP:1297

Urine
Succinylacetone
normal
Apr 2009 (10mo)
Differential Diagnosis
Hereditary Fructose
Intolerance
Differential Diagnosis
GSD - IV

Fanconi
Bickel
syndrome
(GSD with RTA)
Doll Like facies…
What is it ?
Transient
neonatal
cholestasis

Affected sib
with downhill
course

Hyperammonemia
(encephalopathy)
Steatosis &
cirrhosis on
biopsy

Doll like
facies

Citrin
deficiency
Fischers ratio
(BCAA/ArAA)
=2.18
Citrin deficiency
<2.5

Caveat:
Test done during
asymptomatic
phase, not during
crisis!
Lost to follow up

Urine metabolic screen
Sweat chloride
Plasma Chitotriosidase
Sphingomyelinase
Beta-glucosidase
Beta-galactosidase

Apr 2009 (10mo)

normal
AST/ALT: 163/84
T. protein:5.9
Albumin: 2.9
ALP:913
GGT:138
CK: 24
Lipid profile: normal

Persisting:
Doll like facies
Organomegaly
Growth failure

Jan 2012 (3 ½ yrs)
Preference to protein rich foods, loves milk – parents reluctant!
Urine NGRS
+

GSD
workup
negative

High
AFP

H/O Transient
neonatal
cholestasis
(not worked up
anywhere)

SGPGI

GAL1PUT& Epimerase
normal
Urine Succinylacetone normal

Liver biopsy not possible - coagulopathy
Bone Marrow : normal

Failure to thrive
Organomegaly

TB/DB: 0.5/0.1
AST/ALT: 128/60
T. Prot/ Alb: 4.6/2.0
ALP:1505
GGT: 148
INR:1.6
Oct ‘08 (~3yrs)

Craving for protein rich food
Aversion to carbohydrates/ juices
TB/DB: 0.7/0.2
AST/ALT: 156/78
T. Prot/ Alb: 5.4/1.7
ALP:930
INR:1.8
Jan ‘09
Liver failure!

Transient neonatal cholestasis
Urine for metabolic screen
Sphingomyelinase
Beta-glucosidase
Beta-galactosidase

normal

Liver
Transplant
D
E
A
T
H

Recurrent encephalopathy
Off and on ascites
TB/DB: 0.7/0.2
AST/ALT: 156/78
T. Prot/ Alb: 5.4/1.7
ALP:930
INR:1.8

TB/DB: 2.0/1.3
AST/ALT: 121/77
T. Prot/ Alb: 4.5/1.5
ALP:684 GGT:88
INR: 2.3

TB/DB: 14.0/8.8
AST/ALT: 225/73
T. Prot/ Alb: 5.5/1.6
ALP:515
INR: 4.4

Jan ‘09

Dec ‘09 (~4yr)

Apr ‘10 (4 ½ yr)
SLC25A13 gene testing and
mutational analysis not available
Citrin deficiency

Autosomal
Recessive
Carrier frequency of gene mutation
China (1/79)
Taiwan (1/98)
Korea (1/50)
Japan (1/69)

Frequency of homozygous mutation for
SLC25A13 gene :
1:20,000-34,000 (East Asia)
Mol Genet Metab. 2009 Jan;96(1):44-9.

Pediatr Res 2004 Oct;56(4):608-14
Citrin deficiency

Chubby faces
Kobayashi et al Gene Reviews 2005
Recovery

ALF

Citrullinemia CLD
Type II

Chinese NICCD
cohort (n=26)

21 (81%) by 1 5 (19%) :
yr age
4 died, 1
LT

-

-

Retrospective
Japanese series
(n=75)

45 NICCD
30 new born
screening

2 (4.5%)
by 1yr

1 (2.2%) by
16yrs

-

Japanese NICCD
cohort (n=5)

4 recovered
by 1yr

1 LT by
2yr

-

-

Malaysian NICCD
cohort (n=11)

10 (91%)
recovery by
22mo

1 (9%)
died

Chinese
CLD (unknown
etiology) cases
(n=44)

-

-

-

21 patients
(~50%)
(20families)
Mutation+

Song et al ,Zhonghua Er Ke Za Zhi 2009 Aug;47(8):624-7.
Xing et al Zhonghua Xue Za Zhi.2010 Apr;27(2):180-5
Ohura et al J Inherit Metab Dis 2007 Apr;30(2):139-44
Chubby Index = (1+2)/3

Chen HW, JPGN 47:187–192, 2008

Controls (n=13)

Patients (n=5)

13.3
1.336
1.00
Can LFT predict?
Age: 93 days
DB:3.8
TB:7.4
AST:321
ALT: 138
ALP:1672
GGT:66
Chen HW, JPGN 47:187–192, 2008

2.3
0.5
Younger Sib
Total Protein/ Albumin Sep 08:
Total Protein/ Albumin Jan 09:
Total Protein/ Albumin April 09:
Total Protein/ Albumin Jan 12:

Unexplained
Hypoproteinemia!

3.9 / 2.0
4.3 / 2.1

4.0 / 1.8
5.9 / 2.9

Feature of citrin def.
Chen HW, JPGN 47:187–192, 2008

Elder sib Oct 08

Jan 09

Dec 09

Apr 10

AST
ALT
AST/ALT

128
60

156
78

225
97

2.1

2.0

121
77
1.57

ALP
T.Protein
Albumin

1505
4.6
2.0

930
5.4
1.7

684
4.5
1.5

2.3
505
5.5
1.6
Histopathology changes
Steatosis (2/3)

Neonatal Hepatitis like

FibrosisCirrhosis

>50% Citrin deficiency
(Taiwan series)

NASH
NAFLD

May persist
into adulthood

6% Neonatal cholestasis
(Chinese series)
12% Idiopathic neonatal hepatitis
(Japanese series)

Liver
failure
Journal of Pediatric Gastroenterology and Nutrition Jun 2010

21%
diagnosed
NAFLD

19 patients with
Citrullinemia II

90% steatosis
79% fibrosis

Komatsu et al, J Hepatol 2008 Nov;49(5))

Fatty livers without obesity ! BMI <20
High serum Pancreatic secretory trypsin inhibitor (PSTI) >29ng/ml
……Pancreatitis (68%) !
Diagnosis
Citrulline level high
60-73% : NICCD
Japanese series
90%: new born
screening

Chen HW et al, JPGN 47:187–192, 2008
Kobayashi et al Gene Reviews 2005
Tazawa et al, Mol Genetic Metabol 2004;83(3):213-9
Caveats in diagnosis
Literature from Chinese/Japanese articles
Natural History is unclear
Misdiagnosis as Galactosemia and Tyrosinemia
(increase galactose and tyrosine in blood, galactosuria)
Plasma amino acids
Inconsistently and varied elevation
New born screen ineffective
Normal during asymptomatic phase,
GI bleed, high protein intake

Urine GCMS:
Various nonspecific
metabolites
Diet peculiarities
Urea Cycle
defects

Protein
aversion
“My son hates
rice and eats
only fish!”

“…. wants milk 24 x7 !!”
(Seen in Citrullinemia Type II)

Protein craving
Citrin deficiency

Carbohydrate
aversion
Diet recommendations
Protein : 15-20%
Fat : 50%
Carbohydrates: 30-35%
Milk : Protein (20%) Fat (50%) Carb (30%)

Avoid
High carbohydrate / Fructose
Glycerol for brain edema
Liver Transplant
Recurrent encephalopathy
Liver failure
Hepatocellular Carcinoma (5-8%)

Good outcome

Auxillary
Partial
Orthotropic

Kobayashi et al Gene Reviews 2005
Soo Kim, J Korean Surg Soc 2011;80:S51-54
Yazaki, Liver Transplantation, Vol 10, No 4 (April), 2004
All that glitters is not GOLD!
All Chubby cheeks are not GSD!

THANK YOU
Lipids
1)compensate for
energy
2) FA inhibit hepatic
glycolysis

Urea Cycle for
ureagenesis

Protein intake
More availability of aspartate through
aspargine and pyruvate from alanine

Chubby cheeks
Citrate –malate shuttle activated: Increase of
Glycerol 3 phosphate + breakdown of citrate
(Acetyl CoA +OAA)
Hypoproteinemia (subclinical edema)
Unexplained concepts
• Why majority outgrow the disease?
• Any additional factors for progression to
CLD/ALF ?
• Postulation for protein craving?

More Related Content

What's hot

seminar on Thalassemia by Dr. habib Dr. mehadi Dr. asad
seminar on Thalassemia by Dr. habib Dr. mehadi Dr. asadseminar on Thalassemia by Dr. habib Dr. mehadi Dr. asad
seminar on Thalassemia by Dr. habib Dr. mehadi Dr. asadDr. Habibur Rahim
 
Hemolytic anemia in children 2021
Hemolytic anemia in children 2021Hemolytic anemia in children 2021
Hemolytic anemia in children 2021Imran Iqbal
 
Management of Thalassemia
Management of ThalassemiaManagement of Thalassemia
Management of Thalassemiayuyuricci
 
Approach to hypoglycemia in infants and children
Approach to hypoglycemia in infants and childrenApproach to hypoglycemia in infants and children
Approach to hypoglycemia in infants and childrenAbdulmoein AlAgha
 
Complications of Thalassemia major
Complications of Thalassemia majorComplications of Thalassemia major
Complications of Thalassemia majorGirish Bhatt
 
Acute myeloid leukemia
Acute myeloid leukemiaAcute myeloid leukemia
Acute myeloid leukemiaAthira RG
 
Pediatric growth hormone deficiency
Pediatric growth hormone deficiencyPediatric growth hormone deficiency
Pediatric growth hormone deficiencyAbdulmoein AlAgha
 
Thalassemia syndrome
Thalassemia syndromeThalassemia syndrome
Thalassemia syndromerashedadr
 
Thalassemia Case Presentation
Thalassemia Case PresentationThalassemia Case Presentation
Thalassemia Case PresentationDilinaAarewatte
 
Thalassemia syndrome
Thalassemia syndromeThalassemia syndrome
Thalassemia syndromeRahul Arya
 
Acute promyelocytic leukemia
Acute promyelocytic leukemiaAcute promyelocytic leukemia
Acute promyelocytic leukemiaRanjita Pallavi
 
Hemolytic anemia - Approach and Management
Hemolytic anemia - Approach and ManagementHemolytic anemia - Approach and Management
Hemolytic anemia - Approach and ManagementChetan Ganteppanavar
 
Diabetic nephropathy management
Diabetic nephropathy managementDiabetic nephropathy management
Diabetic nephropathy managementNaresh Monigari
 

What's hot (20)

Sickle cell disease
Sickle cell diseaseSickle cell disease
Sickle cell disease
 
seminar on Thalassemia by Dr. habib Dr. mehadi Dr. asad
seminar on Thalassemia by Dr. habib Dr. mehadi Dr. asadseminar on Thalassemia by Dr. habib Dr. mehadi Dr. asad
seminar on Thalassemia by Dr. habib Dr. mehadi Dr. asad
 
Hemolytic anemia in children 2021
Hemolytic anemia in children 2021Hemolytic anemia in children 2021
Hemolytic anemia in children 2021
 
Thalassemia
ThalassemiaThalassemia
Thalassemia
 
thalassemia
thalassemiathalassemia
thalassemia
 
Management of Thalassemia
Management of ThalassemiaManagement of Thalassemia
Management of Thalassemia
 
Approach to hypoglycemia in infants and children
Approach to hypoglycemia in infants and childrenApproach to hypoglycemia in infants and children
Approach to hypoglycemia in infants and children
 
Thalassemia
ThalassemiaThalassemia
Thalassemia
 
Complications of Thalassemia major
Complications of Thalassemia majorComplications of Thalassemia major
Complications of Thalassemia major
 
Neonatal Cholestasis
Neonatal CholestasisNeonatal Cholestasis
Neonatal Cholestasis
 
Acute myeloid leukemia
Acute myeloid leukemiaAcute myeloid leukemia
Acute myeloid leukemia
 
Pediatric growth hormone deficiency
Pediatric growth hormone deficiencyPediatric growth hormone deficiency
Pediatric growth hormone deficiency
 
Thalassemia
ThalassemiaThalassemia
Thalassemia
 
Thalassemia syndrome
Thalassemia syndromeThalassemia syndrome
Thalassemia syndrome
 
Thalassemia Case Presentation
Thalassemia Case PresentationThalassemia Case Presentation
Thalassemia Case Presentation
 
Thalassemia syndrome
Thalassemia syndromeThalassemia syndrome
Thalassemia syndrome
 
Acute promyelocytic leukemia
Acute promyelocytic leukemiaAcute promyelocytic leukemia
Acute promyelocytic leukemia
 
Hemolytic anemia - Approach and Management
Hemolytic anemia - Approach and ManagementHemolytic anemia - Approach and Management
Hemolytic anemia - Approach and Management
 
Fanconi
FanconiFanconi
Fanconi
 
Diabetic nephropathy management
Diabetic nephropathy managementDiabetic nephropathy management
Diabetic nephropathy management
 

Similar to CITRIN DEFICIENCY

Primary biliary cirrhosis and autoimmune hepatitis 20120902
Primary biliary cirrhosis and autoimmune hepatitis 20120902 Primary biliary cirrhosis and autoimmune hepatitis 20120902
Primary biliary cirrhosis and autoimmune hepatitis 20120902 Chien-Wei Su
 
MLD presenting with ALF Talk by Dr SK Yachha
MLD presenting with ALF Talk by Dr SK YachhaMLD presenting with ALF Talk by Dr SK Yachha
MLD presenting with ALF Talk by Dr SK YachhaSanjeev Kumar
 
Advances in cholangiocarcinoma
Advances in cholangiocarcinomaAdvances in cholangiocarcinoma
Advances in cholangiocarcinomaspa718
 
Diagnostic challenges in Wilson disease: do scoring systems help? - Dr Harsha...
Diagnostic challenges in Wilson disease: do scoring systems help? - Dr Harsha...Diagnostic challenges in Wilson disease: do scoring systems help? - Dr Harsha...
Diagnostic challenges in Wilson disease: do scoring systems help? - Dr Harsha...Sanjeev Kumar
 
4-3. Risk factors for IgAN. Rosanna Coppo (eng)
4-3. Risk factors for IgAN. Rosanna Coppo (eng)4-3. Risk factors for IgAN. Rosanna Coppo (eng)
4-3. Risk factors for IgAN. Rosanna Coppo (eng)KidneyOrgRu
 
Hepato-splenic abnormalities in vitiligo - do they exist?
 Hepato-splenic abnormalities in vitiligo - do they exist?  Hepato-splenic abnormalities in vitiligo - do they exist?
Hepato-splenic abnormalities in vitiligo - do they exist? VR Foundation
 
Tyrosinemia case presentation
Tyrosinemia  case presentationTyrosinemia  case presentation
Tyrosinemia case presentationSanjeev Kumar
 
The taming of the sprue
The taming of the sprueThe taming of the sprue
The taming of the sprueEd McDonald
 
Aflibercept in combination with fluorouracil, leucovorin, and irinotecan in t...
Aflibercept in combination with fluorouracil, leucovorin, and irinotecan in t...Aflibercept in combination with fluorouracil, leucovorin, and irinotecan in t...
Aflibercept in combination with fluorouracil, leucovorin, and irinotecan in t...Mary Ondinee Manalo Igot
 
Protocol based approach to metabolic liver disease seema alam
Protocol based approach to metabolic liver disease  seema alamProtocol based approach to metabolic liver disease  seema alam
Protocol based approach to metabolic liver disease seema alamSanjeev Kumar
 
Recurrent pregnancy loss panel discussion
Recurrent pregnancy loss  panel discussionRecurrent pregnancy loss  panel discussion
Recurrent pregnancy loss panel discussionNiranjan Chavan
 
Hepatosplenomegaly how do we approach
Hepatosplenomegaly how do we approachHepatosplenomegaly how do we approach
Hepatosplenomegaly how do we approachSanjeev Kumar
 
Autoimmune Hepatitits .pptx
Autoimmune Hepatitits .pptxAutoimmune Hepatitits .pptx
Autoimmune Hepatitits .pptxMohdJaved879094
 
Crizotinib a8081001 asco 2010 slides
Crizotinib a8081001 asco 2010 slides Crizotinib a8081001 asco 2010 slides
Crizotinib a8081001 asco 2010 slides coolesanum
 
Inborn error of metabolism ( Prenatal & Newborn Screening )
Inborn error of metabolism ( Prenatal & Newborn Screening )Inborn error of metabolism ( Prenatal & Newborn Screening )
Inborn error of metabolism ( Prenatal & Newborn Screening )Dr.Debkumar Ray
 
celiac-disease powerpoint presentation hai
celiac-disease powerpoint presentation haiceliac-disease powerpoint presentation hai
celiac-disease powerpoint presentation haiAnilSharma811261
 
Connective Tissue Diseases
Connective Tissue DiseasesConnective Tissue Diseases
Connective Tissue Diseaseskatejohnpunag
 

Similar to CITRIN DEFICIENCY (20)

Primary biliary cirrhosis and autoimmune hepatitis 20120902
Primary biliary cirrhosis and autoimmune hepatitis 20120902 Primary biliary cirrhosis and autoimmune hepatitis 20120902
Primary biliary cirrhosis and autoimmune hepatitis 20120902
 
Cholestasis 8
Cholestasis 8Cholestasis 8
Cholestasis 8
 
Pead neonatal jaundice
Pead neonatal jaundicePead neonatal jaundice
Pead neonatal jaundice
 
MLD presenting with ALF Talk by Dr SK Yachha
MLD presenting with ALF Talk by Dr SK YachhaMLD presenting with ALF Talk by Dr SK Yachha
MLD presenting with ALF Talk by Dr SK Yachha
 
Advances in cholangiocarcinoma
Advances in cholangiocarcinomaAdvances in cholangiocarcinoma
Advances in cholangiocarcinoma
 
Diagnostic challenges in Wilson disease: do scoring systems help? - Dr Harsha...
Diagnostic challenges in Wilson disease: do scoring systems help? - Dr Harsha...Diagnostic challenges in Wilson disease: do scoring systems help? - Dr Harsha...
Diagnostic challenges in Wilson disease: do scoring systems help? - Dr Harsha...
 
4-3. Risk factors for IgAN. Rosanna Coppo (eng)
4-3. Risk factors for IgAN. Rosanna Coppo (eng)4-3. Risk factors for IgAN. Rosanna Coppo (eng)
4-3. Risk factors for IgAN. Rosanna Coppo (eng)
 
Hepato-splenic abnormalities in vitiligo - do they exist?
 Hepato-splenic abnormalities in vitiligo - do they exist?  Hepato-splenic abnormalities in vitiligo - do they exist?
Hepato-splenic abnormalities in vitiligo - do they exist?
 
Tyrosinemia case presentation
Tyrosinemia  case presentationTyrosinemia  case presentation
Tyrosinemia case presentation
 
The taming of the sprue
The taming of the sprueThe taming of the sprue
The taming of the sprue
 
Aflibercept in combination with fluorouracil, leucovorin, and irinotecan in t...
Aflibercept in combination with fluorouracil, leucovorin, and irinotecan in t...Aflibercept in combination with fluorouracil, leucovorin, and irinotecan in t...
Aflibercept in combination with fluorouracil, leucovorin, and irinotecan in t...
 
Protocol based approach to metabolic liver disease seema alam
Protocol based approach to metabolic liver disease  seema alamProtocol based approach to metabolic liver disease  seema alam
Protocol based approach to metabolic liver disease seema alam
 
Recurrent pregnancy loss panel discussion
Recurrent pregnancy loss  panel discussionRecurrent pregnancy loss  panel discussion
Recurrent pregnancy loss panel discussion
 
Hepatosplenomegaly how do we approach
Hepatosplenomegaly how do we approachHepatosplenomegaly how do we approach
Hepatosplenomegaly how do we approach
 
Autoimmune Hepatitits .pptx
Autoimmune Hepatitits .pptxAutoimmune Hepatitits .pptx
Autoimmune Hepatitits .pptx
 
Crizotinib a8081001 asco 2010 slides
Crizotinib a8081001 asco 2010 slides Crizotinib a8081001 asco 2010 slides
Crizotinib a8081001 asco 2010 slides
 
Inborn error of metabolism ( Prenatal & Newborn Screening )
Inborn error of metabolism ( Prenatal & Newborn Screening )Inborn error of metabolism ( Prenatal & Newborn Screening )
Inborn error of metabolism ( Prenatal & Newborn Screening )
 
Recurrent Pregnancy Loss
Recurrent Pregnancy LossRecurrent Pregnancy Loss
Recurrent Pregnancy Loss
 
celiac-disease powerpoint presentation hai
celiac-disease powerpoint presentation haiceliac-disease powerpoint presentation hai
celiac-disease powerpoint presentation hai
 
Connective Tissue Diseases
Connective Tissue DiseasesConnective Tissue Diseases
Connective Tissue Diseases
 

More from Sanjeev Kumar

6 year old with resistant rickets
6 year old with resistant rickets6 year old with resistant rickets
6 year old with resistant ricketsSanjeev Kumar
 
Wilson Disease - Beyond the liver and brain…- Dr Ujjal Poddar
Wilson Disease - Beyond the liver and brain…- Dr Ujjal PoddarWilson Disease - Beyond the liver and brain…- Dr Ujjal Poddar
Wilson Disease - Beyond the liver and brain…- Dr Ujjal PoddarSanjeev Kumar
 
Role of liver biopsy - Dr Banumathi
Role of liver biopsy - Dr BanumathiRole of liver biopsy - Dr Banumathi
Role of liver biopsy - Dr BanumathiSanjeev Kumar
 
Key publications on wilson disease in last 3 years
Key publications on wilson disease in last 3 yearsKey publications on wilson disease in last 3 years
Key publications on wilson disease in last 3 yearsSanjeev Kumar
 
Acute liver failure with hemolysis
Acute liver failure with hemolysis Acute liver failure with hemolysis
Acute liver failure with hemolysis Sanjeev Kumar
 
When does one use zinc alone - Dr Vinay Goyal
When does one use zinc alone - Dr Vinay GoyalWhen does one use zinc alone - Dr Vinay Goyal
When does one use zinc alone - Dr Vinay GoyalSanjeev Kumar
 
Panel discussion: Developmental, speech, psychiatric and counseling issues - ...
Panel discussion: Developmental, speech, psychiatric and counseling issues - ...Panel discussion: Developmental, speech, psychiatric and counseling issues - ...
Panel discussion: Developmental, speech, psychiatric and counseling issues - ...Sanjeev Kumar
 
Hepatic and Neuro Wilson disease - Is there a difference? - Dr John Matthai
Hepatic and Neuro Wilson disease - Is there a difference? - Dr John MatthaiHepatic and Neuro Wilson disease - Is there a difference? - Dr John Matthai
Hepatic and Neuro Wilson disease - Is there a difference? - Dr John MatthaiSanjeev Kumar
 
Patient with neuro-hepatic Wilson disease- worsened on starting d-penicillami...
Patient with neuro-hepatic Wilson disease- worsened on starting d-penicillami...Patient with neuro-hepatic Wilson disease- worsened on starting d-penicillami...
Patient with neuro-hepatic Wilson disease- worsened on starting d-penicillami...Sanjeev Kumar
 
Panel Discussion - Genetics - Is there a role in clinical practice? - Dr Seem...
Panel Discussion - Genetics - Is there a role in clinical practice? - Dr Seem...Panel Discussion - Genetics - Is there a role in clinical practice? - Dr Seem...
Panel Discussion - Genetics - Is there a role in clinical practice? - Dr Seem...Sanjeev Kumar
 
Choice and Monitoring of drug therapy - Dr Ashish Bavdekar
Choice and Monitoring of drug therapy - Dr Ashish BavdekarChoice and Monitoring of drug therapy - Dr Ashish Bavdekar
Choice and Monitoring of drug therapy - Dr Ashish BavdekarSanjeev Kumar
 
Copper in health and disease - Dr Srinivas Sankaranarayanan
Copper in health and disease - Dr Srinivas SankaranarayananCopper in health and disease - Dr Srinivas Sankaranarayanan
Copper in health and disease - Dr Srinivas SankaranarayananSanjeev Kumar
 
Why did d-penicillamine disappear from the market?
Why did d-penicillamine disappear from the market?Why did d-penicillamine disappear from the market?
Why did d-penicillamine disappear from the market?Sanjeev Kumar
 
Role of MRI in Wilson disease - Dr Sanjib Sinha
Role of MRI in Wilson disease - Dr Sanjib SinhaRole of MRI in Wilson disease - Dr Sanjib Sinha
Role of MRI in Wilson disease - Dr Sanjib SinhaSanjeev Kumar
 
Complications of drug therapy - Dr Malathi Sathiyasekaran
Complications of drug therapy - Dr Malathi SathiyasekaranComplications of drug therapy - Dr Malathi Sathiyasekaran
Complications of drug therapy - Dr Malathi SathiyasekaranSanjeev Kumar
 
How do we monitor neurological improvement - Dr Rukmini Mridula
How do we monitor neurological improvement - Dr Rukmini MridulaHow do we monitor neurological improvement - Dr Rukmini Mridula
How do we monitor neurological improvement - Dr Rukmini MridulaSanjeev Kumar
 
Wilsons disease and hepatitis dr. abhamoni baro
Wilsons disease and hepatitis  dr. abhamoni baroWilsons disease and hepatitis  dr. abhamoni baro
Wilsons disease and hepatitis dr. abhamoni baroSanjeev Kumar
 
Acute viral hepatitis dos and don’ts dr. mani singhal
Acute viral hepatitis dos and don’ts dr. mani singhalAcute viral hepatitis dos and don’ts dr. mani singhal
Acute viral hepatitis dos and don’ts dr. mani singhalSanjeev Kumar
 
Child with acute liver failure dr. kirtichandra kodali
Child with acute liver failure dr.  kirtichandra kodaliChild with acute liver failure dr.  kirtichandra kodali
Child with acute liver failure dr. kirtichandra kodaliSanjeev Kumar
 
Hepatomegaly with seizures and hepatitis in a family dr. rajesh kumar meena
Hepatomegaly with seizures and hepatitis in a family dr. rajesh kumar meenaHepatomegaly with seizures and hepatitis in a family dr. rajesh kumar meena
Hepatomegaly with seizures and hepatitis in a family dr. rajesh kumar meenaSanjeev Kumar
 

More from Sanjeev Kumar (20)

6 year old with resistant rickets
6 year old with resistant rickets6 year old with resistant rickets
6 year old with resistant rickets
 
Wilson Disease - Beyond the liver and brain…- Dr Ujjal Poddar
Wilson Disease - Beyond the liver and brain…- Dr Ujjal PoddarWilson Disease - Beyond the liver and brain…- Dr Ujjal Poddar
Wilson Disease - Beyond the liver and brain…- Dr Ujjal Poddar
 
Role of liver biopsy - Dr Banumathi
Role of liver biopsy - Dr BanumathiRole of liver biopsy - Dr Banumathi
Role of liver biopsy - Dr Banumathi
 
Key publications on wilson disease in last 3 years
Key publications on wilson disease in last 3 yearsKey publications on wilson disease in last 3 years
Key publications on wilson disease in last 3 years
 
Acute liver failure with hemolysis
Acute liver failure with hemolysis Acute liver failure with hemolysis
Acute liver failure with hemolysis
 
When does one use zinc alone - Dr Vinay Goyal
When does one use zinc alone - Dr Vinay GoyalWhen does one use zinc alone - Dr Vinay Goyal
When does one use zinc alone - Dr Vinay Goyal
 
Panel discussion: Developmental, speech, psychiatric and counseling issues - ...
Panel discussion: Developmental, speech, psychiatric and counseling issues - ...Panel discussion: Developmental, speech, psychiatric and counseling issues - ...
Panel discussion: Developmental, speech, psychiatric and counseling issues - ...
 
Hepatic and Neuro Wilson disease - Is there a difference? - Dr John Matthai
Hepatic and Neuro Wilson disease - Is there a difference? - Dr John MatthaiHepatic and Neuro Wilson disease - Is there a difference? - Dr John Matthai
Hepatic and Neuro Wilson disease - Is there a difference? - Dr John Matthai
 
Patient with neuro-hepatic Wilson disease- worsened on starting d-penicillami...
Patient with neuro-hepatic Wilson disease- worsened on starting d-penicillami...Patient with neuro-hepatic Wilson disease- worsened on starting d-penicillami...
Patient with neuro-hepatic Wilson disease- worsened on starting d-penicillami...
 
Panel Discussion - Genetics - Is there a role in clinical practice? - Dr Seem...
Panel Discussion - Genetics - Is there a role in clinical practice? - Dr Seem...Panel Discussion - Genetics - Is there a role in clinical practice? - Dr Seem...
Panel Discussion - Genetics - Is there a role in clinical practice? - Dr Seem...
 
Choice and Monitoring of drug therapy - Dr Ashish Bavdekar
Choice and Monitoring of drug therapy - Dr Ashish BavdekarChoice and Monitoring of drug therapy - Dr Ashish Bavdekar
Choice and Monitoring of drug therapy - Dr Ashish Bavdekar
 
Copper in health and disease - Dr Srinivas Sankaranarayanan
Copper in health and disease - Dr Srinivas SankaranarayananCopper in health and disease - Dr Srinivas Sankaranarayanan
Copper in health and disease - Dr Srinivas Sankaranarayanan
 
Why did d-penicillamine disappear from the market?
Why did d-penicillamine disappear from the market?Why did d-penicillamine disappear from the market?
Why did d-penicillamine disappear from the market?
 
Role of MRI in Wilson disease - Dr Sanjib Sinha
Role of MRI in Wilson disease - Dr Sanjib SinhaRole of MRI in Wilson disease - Dr Sanjib Sinha
Role of MRI in Wilson disease - Dr Sanjib Sinha
 
Complications of drug therapy - Dr Malathi Sathiyasekaran
Complications of drug therapy - Dr Malathi SathiyasekaranComplications of drug therapy - Dr Malathi Sathiyasekaran
Complications of drug therapy - Dr Malathi Sathiyasekaran
 
How do we monitor neurological improvement - Dr Rukmini Mridula
How do we monitor neurological improvement - Dr Rukmini MridulaHow do we monitor neurological improvement - Dr Rukmini Mridula
How do we monitor neurological improvement - Dr Rukmini Mridula
 
Wilsons disease and hepatitis dr. abhamoni baro
Wilsons disease and hepatitis  dr. abhamoni baroWilsons disease and hepatitis  dr. abhamoni baro
Wilsons disease and hepatitis dr. abhamoni baro
 
Acute viral hepatitis dos and don’ts dr. mani singhal
Acute viral hepatitis dos and don’ts dr. mani singhalAcute viral hepatitis dos and don’ts dr. mani singhal
Acute viral hepatitis dos and don’ts dr. mani singhal
 
Child with acute liver failure dr. kirtichandra kodali
Child with acute liver failure dr.  kirtichandra kodaliChild with acute liver failure dr.  kirtichandra kodali
Child with acute liver failure dr. kirtichandra kodali
 
Hepatomegaly with seizures and hepatitis in a family dr. rajesh kumar meena
Hepatomegaly with seizures and hepatitis in a family dr. rajesh kumar meenaHepatomegaly with seizures and hepatitis in a family dr. rajesh kumar meena
Hepatomegaly with seizures and hepatitis in a family dr. rajesh kumar meena
 

Recently uploaded

Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991RKavithamani
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsKarinaGenton
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
PSYCHIATRIC History collection FORMAT.pptx
PSYCHIATRIC   History collection FORMAT.pptxPSYCHIATRIC   History collection FORMAT.pptx
PSYCHIATRIC History collection FORMAT.pptxPoojaSen20
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesFatimaKhan178732
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxpboyjonauth
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
Micromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of PowdersMicromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of PowdersChitralekhaTherkar
 

Recently uploaded (20)

Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
Industrial Policy - 1948, 1956, 1973, 1977, 1980, 1991
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Tilak Nagar Delhi reach out to us at 🔝9953056974🔝
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 
Science 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its CharacteristicsScience 7 - LAND and SEA BREEZE and its Characteristics
Science 7 - LAND and SEA BREEZE and its Characteristics
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
PSYCHIATRIC History collection FORMAT.pptx
PSYCHIATRIC   History collection FORMAT.pptxPSYCHIATRIC   History collection FORMAT.pptx
PSYCHIATRIC History collection FORMAT.pptx
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and Actinides
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Introduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptxIntroduction to AI in Higher Education_draft.pptx
Introduction to AI in Higher Education_draft.pptx
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
Micromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of PowdersMicromeritics - Fundamental and Derived Properties of Powders
Micromeritics - Fundamental and Derived Properties of Powders
 

CITRIN DEFICIENCY

  • 1. Story of two siblings with “Chubby Cheeks” Dept. of Pediatric Gastroenterology SGPGIMS, Lucknow
  • 2. Chubby cheeks – cute babies?
  • 3. GSD workup negative Exposure to fruit juices Affected SIB Neonatal cholestasis TB:7.4 DB:3.8 AST:321 ALT: 138 T. Prot:3.9 Alb: 2.0 ALP:1672 GGT:66 Resolved by 5mo Sep 2008 (3mo) Acute encephalopathy Liver biopsy: early cirrhosis macrovesicular steatosis Urine NGRS + High AFP ABG/ Blood sugar/ U. ketones/ Lactate All normal ! Ammonia :119 (Normal:11-47) GAL1PUT & Epimerase normal Persisting: Doll like facies Organomegaly AST/ALT: 253/180 T. Prot/ Alb: 4.0/1.8 ALP:1297 Urine Succinylacetone normal Apr 2009 (10mo)
  • 5. Differential Diagnosis GSD - IV Fanconi Bickel syndrome (GSD with RTA)
  • 6. Doll Like facies… What is it ? Transient neonatal cholestasis Affected sib with downhill course Hyperammonemia (encephalopathy) Steatosis & cirrhosis on biopsy Doll like facies Citrin deficiency
  • 7. Fischers ratio (BCAA/ArAA) =2.18 Citrin deficiency <2.5 Caveat: Test done during asymptomatic phase, not during crisis!
  • 8. Lost to follow up Urine metabolic screen Sweat chloride Plasma Chitotriosidase Sphingomyelinase Beta-glucosidase Beta-galactosidase Apr 2009 (10mo) normal AST/ALT: 163/84 T. protein:5.9 Albumin: 2.9 ALP:913 GGT:138 CK: 24 Lipid profile: normal Persisting: Doll like facies Organomegaly Growth failure Jan 2012 (3 ½ yrs)
  • 9. Preference to protein rich foods, loves milk – parents reluctant!
  • 10. Urine NGRS + GSD workup negative High AFP H/O Transient neonatal cholestasis (not worked up anywhere) SGPGI GAL1PUT& Epimerase normal Urine Succinylacetone normal Liver biopsy not possible - coagulopathy Bone Marrow : normal Failure to thrive Organomegaly TB/DB: 0.5/0.1 AST/ALT: 128/60 T. Prot/ Alb: 4.6/2.0 ALP:1505 GGT: 148 INR:1.6 Oct ‘08 (~3yrs) Craving for protein rich food Aversion to carbohydrates/ juices TB/DB: 0.7/0.2 AST/ALT: 156/78 T. Prot/ Alb: 5.4/1.7 ALP:930 INR:1.8 Jan ‘09
  • 11. Liver failure! Transient neonatal cholestasis Urine for metabolic screen Sphingomyelinase Beta-glucosidase Beta-galactosidase normal Liver Transplant D E A T H Recurrent encephalopathy Off and on ascites TB/DB: 0.7/0.2 AST/ALT: 156/78 T. Prot/ Alb: 5.4/1.7 ALP:930 INR:1.8 TB/DB: 2.0/1.3 AST/ALT: 121/77 T. Prot/ Alb: 4.5/1.5 ALP:684 GGT:88 INR: 2.3 TB/DB: 14.0/8.8 AST/ALT: 225/73 T. Prot/ Alb: 5.5/1.6 ALP:515 INR: 4.4 Jan ‘09 Dec ‘09 (~4yr) Apr ‘10 (4 ½ yr)
  • 12. SLC25A13 gene testing and mutational analysis not available
  • 14. Carrier frequency of gene mutation China (1/79) Taiwan (1/98) Korea (1/50) Japan (1/69) Frequency of homozygous mutation for SLC25A13 gene : 1:20,000-34,000 (East Asia) Mol Genet Metab. 2009 Jan;96(1):44-9. Pediatr Res 2004 Oct;56(4):608-14
  • 15. Citrin deficiency Chubby faces Kobayashi et al Gene Reviews 2005
  • 16. Recovery ALF Citrullinemia CLD Type II Chinese NICCD cohort (n=26) 21 (81%) by 1 5 (19%) : yr age 4 died, 1 LT - - Retrospective Japanese series (n=75) 45 NICCD 30 new born screening 2 (4.5%) by 1yr 1 (2.2%) by 16yrs - Japanese NICCD cohort (n=5) 4 recovered by 1yr 1 LT by 2yr - - Malaysian NICCD cohort (n=11) 10 (91%) recovery by 22mo 1 (9%) died Chinese CLD (unknown etiology) cases (n=44) - - - 21 patients (~50%) (20families) Mutation+ Song et al ,Zhonghua Er Ke Za Zhi 2009 Aug;47(8):624-7. Xing et al Zhonghua Xue Za Zhi.2010 Apr;27(2):180-5 Ohura et al J Inherit Metab Dis 2007 Apr;30(2):139-44
  • 17. Chubby Index = (1+2)/3 Chen HW, JPGN 47:187–192, 2008 Controls (n=13) Patients (n=5) 13.3 1.336 1.00
  • 18. Can LFT predict? Age: 93 days DB:3.8 TB:7.4 AST:321 ALT: 138 ALP:1672 GGT:66 Chen HW, JPGN 47:187–192, 2008 2.3 0.5
  • 19. Younger Sib Total Protein/ Albumin Sep 08: Total Protein/ Albumin Jan 09: Total Protein/ Albumin April 09: Total Protein/ Albumin Jan 12: Unexplained Hypoproteinemia! 3.9 / 2.0 4.3 / 2.1 4.0 / 1.8 5.9 / 2.9 Feature of citrin def. Chen HW, JPGN 47:187–192, 2008 Elder sib Oct 08 Jan 09 Dec 09 Apr 10 AST ALT AST/ALT 128 60 156 78 225 97 2.1 2.0 121 77 1.57 ALP T.Protein Albumin 1505 4.6 2.0 930 5.4 1.7 684 4.5 1.5 2.3 505 5.5 1.6
  • 20. Histopathology changes Steatosis (2/3) Neonatal Hepatitis like FibrosisCirrhosis >50% Citrin deficiency (Taiwan series) NASH NAFLD May persist into adulthood 6% Neonatal cholestasis (Chinese series) 12% Idiopathic neonatal hepatitis (Japanese series) Liver failure
  • 21. Journal of Pediatric Gastroenterology and Nutrition Jun 2010 21% diagnosed NAFLD 19 patients with Citrullinemia II 90% steatosis 79% fibrosis Komatsu et al, J Hepatol 2008 Nov;49(5)) Fatty livers without obesity ! BMI <20 High serum Pancreatic secretory trypsin inhibitor (PSTI) >29ng/ml ……Pancreatitis (68%) !
  • 22. Diagnosis Citrulline level high 60-73% : NICCD Japanese series 90%: new born screening Chen HW et al, JPGN 47:187–192, 2008 Kobayashi et al Gene Reviews 2005 Tazawa et al, Mol Genetic Metabol 2004;83(3):213-9
  • 23. Caveats in diagnosis Literature from Chinese/Japanese articles Natural History is unclear Misdiagnosis as Galactosemia and Tyrosinemia (increase galactose and tyrosine in blood, galactosuria) Plasma amino acids Inconsistently and varied elevation New born screen ineffective Normal during asymptomatic phase, GI bleed, high protein intake Urine GCMS: Various nonspecific metabolites
  • 24. Diet peculiarities Urea Cycle defects Protein aversion “My son hates rice and eats only fish!” “…. wants milk 24 x7 !!” (Seen in Citrullinemia Type II) Protein craving Citrin deficiency Carbohydrate aversion
  • 25. Diet recommendations Protein : 15-20% Fat : 50% Carbohydrates: 30-35% Milk : Protein (20%) Fat (50%) Carb (30%) Avoid High carbohydrate / Fructose Glycerol for brain edema
  • 26. Liver Transplant Recurrent encephalopathy Liver failure Hepatocellular Carcinoma (5-8%) Good outcome Auxillary Partial Orthotropic Kobayashi et al Gene Reviews 2005 Soo Kim, J Korean Surg Soc 2011;80:S51-54 Yazaki, Liver Transplantation, Vol 10, No 4 (April), 2004
  • 27. All that glitters is not GOLD! All Chubby cheeks are not GSD! THANK YOU
  • 28.
  • 29. Lipids 1)compensate for energy 2) FA inhibit hepatic glycolysis Urea Cycle for ureagenesis Protein intake More availability of aspartate through aspargine and pyruvate from alanine Chubby cheeks Citrate –malate shuttle activated: Increase of Glycerol 3 phosphate + breakdown of citrate (Acetyl CoA +OAA) Hypoproteinemia (subclinical edema)
  • 30. Unexplained concepts • Why majority outgrow the disease? • Any additional factors for progression to CLD/ALF ? • Postulation for protein craving?